# Fibrous Dysplasia Meets Intramuscular Myxoma: Mazabraud Syndrome—First Documented Case in Pakistan

**Authors:** Alizah Faisal, Asfand Yar Ali, Hooria Waqas, Hania Masood, Muhammad Sheraz Hameed, Noor Ul Huda Al Hadi, Rahmat Gul Omarzai

PMC · DOI: 10.1155/carm/3804294 · Case Reports in Medicine · 2026-02-26

## TL;DR

This paper reports the first documented case of Mazabraud syndrome in Pakistan, a rare genetic disorder involving bone deformities and soft tissue tumors.

## Contribution

The first confirmed case of Mazabraud syndrome in Pakistan, highlighting its clinical features and diagnostic challenges in resource-limited settings.

## Key findings

- Mazabraud syndrome was diagnosed in a 64-year-old male with polyostotic fibrous dysplasia and multiple intramuscular myxomas.
- The case highlights the importance of multidisciplinary evaluation for accurate diagnosis in regions with limited genetic testing.
- Timely diagnosis can prevent severe bone deformities and unnecessary aggressive treatments.

## Abstract

Mazabraud syndrome (MS) is a rare benign genetic disorder characterized by the coexistence of fibrous dysplasia (FD) and intramuscular myxoma (IM), with a very limited number of cases reported worldwide, and none has been documented in Pakistan until now. It typically presents in middle‐aged females and affects the lower limbs. Its pathogenesis is associated with activating mutations in the GNAS gene. This disease is often under‐recognized in low‐income countries. It can rapidly progress to bone deformities, fractures, and unnecessary aggressive treatments if not promptly recognized.

A 64‐year‐old male presented with progressive fatigue and pallor for three months, alongside a lifelong history of multiple bone deformities and painless soft tissue swellings. He had recurrent fractures since childhood, leading to severe limb deformities and dependence on crutches. Physical exam revealed bosselated swellings over the axilla, thigh, and groin, with significant limb shortening. Imaging showed widespread lytic lesions and necrotic soft tissue masses. Blood work revealed hypochromic microcytic anemia with rouleaux formation; white cell and platelet counts were normal. Bone marrow biopsy demonstrated Grade III myelofibrosis with characteristic “Chinese letter” trabeculae, confirming FD. Biopsy of soft tissue masses showed benign IMs. A diagnosis of MS was made based on the coexistence of polyostotic FD and multiple myxomas.

MS is a rare and benign genetic disorder that requires a high index of suspicion for timely diagnosis. This unique case underscores the need for increased clinical awareness of MS in resource‐limited settings where genetic testing is not common and the importance of multidisciplinary evaluation for accurate diagnosis and management. Timely diagnosis and treatment can prevent bone deformities, fractures, and disabilities and improve patient outcomes for this uncommon syndrome.

## Linked entities

- **Genes:** GNAS (GNAS complex locus) [NCBI Gene 2778]
- **Diseases:** Mazabraud syndrome (MONDO:0018933), fibrous dysplasia (MONDO:0000845), myelofibrosis (MONDO:0044903), hypochromic microcytic anemia (MONDO:0000387)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, CALR (calreticulin) [NCBI Gene 811] {aka CALR1, CRT, HEL-S-99n, RO, SSA, cC1qR}, GNAS (GNAS complex locus) [NCBI Gene 2778] {aka AHO, AIMAH1, C20orf45, GNAS1, GPSA, GSA}, MPL (MPL proto-oncogene, thrombopoietin receptor) [NCBI Gene 4352] {aka C-MPL, CD110, MPLV, THCYT2, THPOR, TPOR}
- **Diseases:** impaired mobility (MESH:D014086), humerus (MESH:D006810), soft tissue neoplasms (MESH:D012983), ulcerative lesion (MESH:D014456), bone deformities (MESH:D001847), marrow (MESH:D001855), Infection (MESH:D007239), IMs (MESH:C563666), tenderness (MESH:D063806), deformity (MESH:D009140), thyroid abnormalities (MESH:D013959), cellulitis (MESH:D002481), bony deformities (MESH:D018213), femoral fracture (MESH:D005264), anemia of chronic disease (MESH:D002908), chondrosarcoma (MESH:D002813), soft tissue myxomas (MESH:D017695), hypochromic anemia (MESH:D000747), necrotic (MESH:D009336), myeloid hyperplasia (MESH:D006965), hypochromic microcytic anemia (MESH:C536357), erythema (MESH:D004890), limb deformities (MESH:D017880), FD (MESH:D005357), MS (MESH:D013577), benign bone tumors (MESH:D001859), fractures (MESH:D050723), pain (MESH:D010146), fibrosis (MESH:D005355), inflammation (MESH:D007249), osteosarcoma (MESH:D012516), swelling (MESH:D004487), deformity of the right femur (MESH:D000092524), MPNs (MESH:D009369), McCune-Albright syndrome (MESH:D005359), fibrosarcoma (MESH:D005354), myelofibrosis (MESH:D055728), malignant fibrous histiocytoma (MESH:D051677), fatigue (MESH:D005221), lytic lesions (MESH:D009059), structural deformities (MESH:D020914), IM (MESH:D009232), inguinal mass (MESH:C536030), bone formation (MESH:D058426), fibrous dysplastic lesion (MESH:D004416), fragility fractures (MESH:D005600), benign genetic disorder (MESH:D030342), neurological deficits (MESH:D009461)
- **Chemicals:** Masson (-), bisphosphonate (MESH:D004164), Tc-99m (MESH:D013667)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945696/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945696/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945696/full.md

---
Source: https://tomesphere.com/paper/PMC12945696